BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34928285)

  • 1. Encapsulation of bryostatin-1 by targeted exosomes enhances remyelination and neuroprotection effects in the cuprizone-induced demyelinating animal model of multiple sclerosis.
    Wu XY; Liao BY; Xiao D; Wu WC; Xiao Y; Alexander T; Song SJ; Zhao ZH; Zhang Y; Wang ZH; Wang LB; Li X
    Biomater Sci; 2022 Feb; 10(3):714-727. PubMed ID: 34928285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered PDGFA-ligand-modified exosomes delivery T3 for demyelinating disease targeted therapy.
    Wang LB; Liao BY; Li YJ; Wang ZH; Yu Y; Li X; Zhang QH
    Exp Neurol; 2024 May; 375():114730. PubMed ID: 38401853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A targeted extracellular vesicles loaded with montelukast in the treatment of demyelinating diseases.
    Xiao Y; Zhang Y; Gao YH; Zhao ZH; He J; Gao R; Guo YX; Wang LB; Li X
    Biochem Biophys Res Commun; 2022 Feb; 594():31-37. PubMed ID: 35066377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neural Stem Cells of the Subventricular Zone Contribute to Neuroprotection of the Corpus Callosum after Cuprizone-Induced Demyelination.
    Butti E; Bacigaluppi M; Chaabane L; Ruffini F; Brambilla E; Berera G; Montonati C; Quattrini A; Martino G
    J Neurosci; 2019 Jul; 39(28):5481-5492. PubMed ID: 31138656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosome-specific loading Sox10 for the treatment of Cuprizone-induced demyelinating model.
    He J; Wang Y; Zhao ZH; He JY; Gao MY; Wang JQ; Wang LB; Zhang Y; Li X
    Biomed Pharmacother; 2024 Feb; 171():116128. PubMed ID: 38218078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomes derived from bone marrow mesenchymal stromal cells promote remyelination and reduce neuroinflammation in the demyelinating central nervous system.
    Zhang J; Buller BA; Zhang ZG; Zhang Y; Lu M; Rosene DL; Medalla M; Moore TL; Chopp M
    Exp Neurol; 2022 Jan; 347():113895. PubMed ID: 34653510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination.
    Mullin AP; Cui C; Wang Y; Wang J; Troy E; Caggiano AO; Parry TJ; Colburn RW; Pavlopoulos E
    Neurobiol Dis; 2017 Sep; 105():142-155. PubMed ID: 28576706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting TrkB with a Brain-Derived Neurotrophic Factor Mimetic Promotes Myelin Repair in the Brain.
    Fletcher JL; Wood RJ; Nguyen J; Norman EML; Jun CMK; Prawdiuk AR; Biemond M; Nguyen HTH; Northfield SE; Hughes RA; Gonsalvez DG; Xiao J; Murray SS
    J Neurosci; 2018 Aug; 38(32):7088-7099. PubMed ID: 29976621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of sequential growth factor delivery during cuprizone challenge in mice aimed to enhance oligodendrogliogenesis and myelin repair.
    Sabo JK; Aumann TD; Kilpatrick TJ; Cate HS
    PLoS One; 2013; 8(5):e63415. PubMed ID: 23650566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antibody rHIgM22 facilitates hippocampal remyelination and ameliorates memory deficits in the cuprizone mouse model of demyelination.
    Cui C; Wang J; Mullin AP; Caggiano AO; Parry TJ; Colburn RW; Pavlopoulos E
    Brain Res; 2018 Sep; 1694():73-86. PubMed ID: 29775564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EBI2 is expressed in glial cells in multiple sclerosis lesions, and its knock-out modulates remyelination in the cuprizone model.
    Klejbor I; Shimshek DR; Klimaszewska-Łata J; Velasco-Estevez M; Moryś J; Karaszewski B; Szutowicz A; Rutkowska A
    Eur J Neurosci; 2021 Aug; 54(3):5173-5188. PubMed ID: 34145920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain region-specific enhancement of remyelination and prevention of demyelination by the CSF1R kinase inhibitor BLZ945.
    Beckmann N; Giorgetti E; Neuhaus A; Zurbruegg S; Accart N; Smith P; Perdoux J; Perrot L; Nash M; Desrayaud S; Wipfli P; Frieauff W; Shimshek DR
    Acta Neuropathol Commun; 2018 Feb; 6(1):9. PubMed ID: 29448957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative temporal changes in DTI values coupled with histological properties in cuprizone-induced demyelination and remyelination.
    Yano R; Hata J; Abe Y; Seki F; Yoshida K; Komaki Y; Okano H; Tanaka KF
    Neurochem Int; 2018 Oct; 119():151-158. PubMed ID: 29030079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fasudil enhances the phagocytosis of myelin debris and the expression of neurotrophic factors in cuprizone-induced demyelinating mice.
    Ding ZB; Han QX; Wang Q; Song LJ; Chu GG; Guo MF; Chai Z; Yu JZ; Xiao BG; Li XY; Ma CG
    Neurosci Lett; 2021 May; 753():135880. PubMed ID: 33838256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repurposing of Secukinumab as Neuroprotective in Cuprizone-Induced Multiple Sclerosis Experimental Model via Inhibition of Oxidative, Inflammatory, and Neurodegenerative Signaling.
    Abdel-Maged AE; Gad AM; Rashed LA; Azab SS; Mohamed EA; Awad AS
    Mol Neurobiol; 2020 Aug; 57(8):3291-3306. PubMed ID: 32514862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new model of cuprizone-mediated demyelination/remyelination.
    Sachs HH; Bercury KK; Popescu DC; Narayanan SP; Macklin WB
    ASN Neuro; 2014; 6(5):. PubMed ID: 25290063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cordycepin (3'-deoxyadenosine) promotes remyelination via suppression of neuroinflammation in a cuprizone-induced mouse model of demyelination.
    Jia Y; Li H; Bao H; Zhang D; Feng L; Xiao Y; Zhu K; Hou Y; Luo S; Zhang Y; Xiao L; Chen X; Zhou J; Wang C; Wang G; Yu H; Xiao C; Du J
    Int Immunopharmacol; 2019 Oct; 75():105777. PubMed ID: 31357085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The flavonoid Baicalein attenuates cuprizone-induced demyelination via suppression of neuroinflammation.
    Hashimoto M; Yamamoto S; Iwasa K; Yamashina K; Ishikawa M; Maruyama K; Bosetti F; Yoshikawa K
    Brain Res Bull; 2017 Oct; 135():47-52. PubMed ID: 28923306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation strategy to determine reliable demyelination in the cuprizone model.
    Chrzanowski U; Schmitz C; Horn-Bochtler A; Nack A; Kipp M
    Metab Brain Dis; 2019 Apr; 34(2):681-685. PubMed ID: 30607821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system.
    Matsushima GK; Morell P
    Brain Pathol; 2001 Jan; 11(1):107-16. PubMed ID: 11145196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.